Nanotech and Cannabidiol

Nano CBD is quickly becoming one of the most popular ways to use CBD. It is any product that contains tiny particles of CBD suspended in either oil or water. The particles are so small, and it’s practically impossible to detect them with the naked eye.

But what are the benefits of these tiny CBD particles? And why are products that contain nano CBD becoming so widely used? There are four main benefits of nanotech—and all of them have to do with the body absorbing CBD faster and more efficiently.

Higher Bioavailability

Who wouldn’t want a product that works better and faster? Nano CBD products offer higher bioavailability than other forms of CBD.

CBD molecules are lipophilic, which means they bind to fat. Using oils as suspending agents for nanoparticles is the perfect solution because it enhances absorption and makes their benefits available quickly and efficiently.

Due to their lipophilic nature, CBD particles can diffuse through the cell membrane and travel throughout the body. Their increased absorption rates allow them to deliver a more concentrated dosage of CBD where it is needed most. If you need a dosage of 10mg, for example, you could take one nano product with 10mg instead of two products, each with 5mg. Get more

What Are the Different Types of CBD Oil Products on the Market Today

CBD is the non-psychoactive compound found in cannabis that comprises up to 40% of the plant’s genetic makeup. CBD products can be hemp-derived or marijuana-derived.

Marijuana-based CBD products can have higher levels of THC (tetrahydrocannabinol). THC is the other primary element of cannabis known for giving a high to those who ingest it. All marijuana-derived CBD products are either regulated or banned in the United States.

Hemp-based CBD products contain less than 0.3% of THC. With very low levels of THC, hemp-derived CBD products can be purchased at a variety of locations. Both the convenience and known benefits of hemp-derived products are why the CBD oil industry is booming!

Types of CBD Oil

For context, there are three compounds that make up the cannabis plant, cannabinoids, terpenes, and flavonoids. CBD and THC both come from the cannabinoid compound. The cannabinoid compound is responsible for producing therapeutic and psychoactive effects.

Terpenes affect the plant’s fragrance and can also have therapeutic effects. Similar to a lavender smell having a calming effect. Read more

Tailored Medicare Billing Compliance Policies and Procedures

Providers that bill Medicare for cardiovascular stress testing must follow custom-tailored billing compliance policies and procedures. These policies and procedures must address all pertinent rules and regulations, and they must do so in a way that facilitates compliance within the context of their unique operations. Too often, health care providers rely on off-the-shelf compliance programs purchased from vendors, and in doing so they fail to address the specific risks they face on a day-to-day basis.

If a provider’s Medicare billing compliance policies and procedures do not address the provider’s specific risks, then they are not going to serve their intended purpose. This is particularly true with regard to nuanced areas of compliance such as cardiovascular stress testing. Providers will make mistakes, and they will face adverse consequences as a result.

As mentioned above, maintaining adequate documentation is critical for demonstrating compliance in the event of a Medicare audit or billing fraud investigation. With regard to cardiovascular stress testing, documentation of medical necessity is particularly important. In order to avoid allegations of fraudulently billing Medicare for excessive and unnecessary tests, providers must be able to demonstrate (with documentation) that they have affirmatively considered the eligibility criteria for these tests. Even if a cardiovascular stress test is eligible based on the reason for which it was conducted, if a provider cannot substantiate this reasoning, it could still face liability for recoupments and other penalties.

For more information click here https://www.jdsupra.com/legalnews/federal-authorities-place-8579972/

Opening a Dialogue with the U.S. Attorney’s Office

In addition to, or possibly in lieu of, filing a motion to quash, targets facing potential grand jury indictments should rely on their defense counsel to open a dialogue with the U.S. Attorney’s Office. Not only can this set the stage for future plea deal negotiations (if necessary), but it can also serve to help facilitate a favorable outcome at the grand jury stage as well. 

Defense counsel will need to make informed and strategic decisions about matters such as whether to file a motion to quash or attempt to negotiate first, whether to offer cooperation in a related investigation, and whether there is a reasonable possibility of securing a favorable pre-charge result. Based on the assessment of these matters (among others), defense counsel can then determine the most advantageous path forward in light of the circumstances at hand and the information that is available.   Get more

Compliance Concerns for Respiratory and Clinical Labs Performing COVID-19 Testing

 

The tragedy of the COVID-19 pandemic is something we all agree we wish we could have avoided. However, the fact of the matter is that many respiratory and clinical labs have seen a boon to their bottom line due to the significant increase in lab tests brought about by widespread testing for COVID-19. For example, in March 2021, labs had processed more than 363 million COVID tests, which averages out to about 1.1 tests per U.S. citizen. This number is rapidly growing as, each day, labs process more than one million COVID tests.

That said, initially, COVID testing got off to a slow start. The result was that the federal government did little to regulate respiratory and clinical labs in the processing of samples for fear of standing in the way of getting the disease under control. However, now that a vaccine is available, much of the country is vaccinated, and the disease (at least temporarily) appears to be under control, the federal government is cracking down on respiratory and clinical labs performing COVID-19 testing.

By some estimates, upwards of 80% of all COVID tests are processed by private labs. Clinical labs face complex regulatory requirements when ensuring they comply with current federal laws, especially in the wake of the pandemic. Thus, it is essential that respiratory and clinical labs performing COVID testing ensure that their procedures and policies are compliant with the current regulatory framework.

For more information visit here https://www.jdsupra.com/legalnews/compliance-concerns-for-respiratory-and-4460313/